Metabolic dysfunction-associated fatty liver disease in the elderly with diabetic foot ulcers: A longitudinal cohort study

被引:0
|
作者
Zhang, Liya [1 ]
Lin, Yuanmei [2 ]
Huang, Xiuxian [2 ]
Zhai, Zhenwei [2 ]
Wei, Rongyan [2 ]
Mo, Jiacheng [3 ,4 ]
Li, Junjun [5 ,6 ]
Lu, Wensheng [2 ,7 ]
机构
[1] Shanxi Yingkang Healthcare Gen Hosp, Dept Endocrinol, Yuncheng, Peoples R China
[2] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Endocrinol & Metab, Nanning, Peoples R China
[3] Guangxi Acad Med Sci, Informat Network Ctr, Nanning, Peoples R China
[4] Peoples Hosp Guangxi Zhuang Autonomous Reg, Nanning, Peoples R China
[5] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Deans Off, Nanning, Peoples R China
[6] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Deans Off, Nanning 530021, Guangxi, Peoples R China
[7] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Endocrinol & Metab, Nanning 530021, Guangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
diabetic foot ulcers; metabolic dysfunction-associated fatty liver disease; ulcer recurrence; CLASSIFICATION; COMPLICATIONS;
D O I
10.1111/iwj.14586
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
This study aimed to explore the association between metabolic-associated fatty liver disease (MAFLD) and ulcer recurrence risk in patients with diabetic foot ulcers (DFUs) through an ambispective longitudinal cohort. From December 2013 to December 2022, a total of 482 inpatients with DFUs (PEDIS grade 3 and above with a severe infection) were eligible for inclusion in this study. This was an ambispective longitudinal cohort study. All participants were followed up every 6 months for 9 years with a median of 36 months. According to whether having MAFLD or not, all subjects were placed into two groups: non-MAFLD (n = 351) and MAFLD (n = 131). The association between MAFLD and ulcer recurrence in patients with DFUs was then evaluated through multivariate Cox regression analysis, stratified analyses and Kaplan-Meier survival analysis. Throughout the follow-up period, out of 482 subjects with DFUs, 68 had ulcer recurrence (14.1%). Three Cox regression models were established for data analyses. In the model I (unadjusted), MAFLD was significantly associated with the ulcer recurrence rate in patients with DFUs (HR = 1.79; 95% CI = 1.097-2.92; p = 0.02). Model II (adjusted model I with gender and age) (HR = 1.781; 95% CI = 1.09-2.912; p = 0.021) and model III (adjusted model II with CVD, duration of diabetes and Cr.) (HR = 1.743; 95% CI = 1.065-2.855; p = 0.027) also showed that MAFLD was significantly related to the ulcer recurrence risk in patients with DFUs, respectively. Stratified analysis indicated that subjects aged >= 60 had a greater risk of ulcer recurrence in MAFLD than in non-MAFLD (HR = 2.31; 95% CI = 1.268-4.206; p = 0.006). Kaplan-Meier survival curve analysis showed that ulcer recurrence rate had a significant association with MAFLD (log-rank, p = 0.018). This study indicated a close association between ulcer recurrence risk and MAFLD in patients with DFUs, especially in the elderly (aged >= 60). Therefore, special attention should be paid to the elderly with both DFUs and MAFLD because they have a higher ulcer recurrence rate than other general populations in routine clinical practice.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Metabolic Dysfunction-Associated Steatotic Liver Disease vs. Metabolic Dysfunction-Associated Fatty Liver Disease: Which Option is the Better Choice?
    Gambardella, Maria Luisa
    Abenavoli, Ludovico
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2025, 86 (02)
  • [42] Influence of alcohol on newly developed metabolic dysfunction-associated fatty liver disease in both sexes: A longitudinal study
    Sogabe, Masahiro
    Okahisa, Toshiya
    Kagawa, Miwako
    Ueda, Hiroyuki
    Kagemoto, Kaizo
    Tanaka, Hironori
    Kida, Yoshifumi
    Tomonari, Tetsu
    Taniguchi, Tatsuya
    Okamoto, Koichi
    Miyamoto, Hiroshi
    Sato, Yasushi
    Nakasono, Masahiko
    Takayama, Tetsuji
    CLINICAL NUTRITION, 2023, 42 (05) : 810 - 816
  • [43] Metabolic dysfunction-associated fatty liver disease and liver function markers are associated with Crohn's disease but not Ulcerative Colitis: a prospective cohort study
    Chen, Jie
    Dan, Lintao
    Tu, Xinru
    Sun, Yuhao
    Deng, Minzi
    Chen, Xuejie
    Hesketh, Therese
    Li, Ran
    Wang, Xiaoyan
    Li, Xue
    HEPATOLOGY INTERNATIONAL, 2023, 17 (01) : 202 - 214
  • [44] Metabolic dysfunction-associated fatty liver disease and liver function markers are associated with Crohn’s disease but not Ulcerative Colitis: a prospective cohort study
    Jie Chen
    Lintao Dan
    Xinru Tu
    Yuhao Sun
    Minzi Deng
    Xuejie Chen
    Therese Hesketh
    Ran Li
    Xiaoyan Wang
    Xue Li
    Hepatology International, 2023, 17 : 202 - 214
  • [45] Age at menopause and risk of metabolic dysfunction-associated fatty liver disease: A 14-year cohort study
    Kim, Ehn-Young
    Lee, Yae-Ji
    Kwon, Yu-Jin
    Lee, Ji-Won
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (11) : 1880 - 1886
  • [46] Associations between metabolic dysfunction-associated fatty liver disease and extrahepatic cancers: a cohort in China
    Yuan, Xiaojie
    Wang, Xiaomo
    Wu, Shouling
    Chen, Shuohua
    Wang, Yanhong
    Wang, Jierui
    Lu, Ying
    Sun, Yuanyuan
    Fu, Qingjiang
    Wang, Li
    HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (05) : 671 - +
  • [47] Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
    Lim, Soo
    Kim, Jin-Wook
    Targher, Giovanni
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2021, 32 (07): : 500 - 514
  • [48] Fasting serum fructose is associated with metabolic dysfunction-associated fatty liver disease: A prospective study
    Fan, Yujuan
    Zhang, Yuecheng
    Chen, Congling
    Ying, Zhen
    Su, Qing
    Li, Xiaoying
    Chen, Ying
    HEPATOLOGY RESEARCH, 2023, 53 (06) : 479 - 488
  • [49] Quality of Life in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease
    Hwang, Tae-In
    Han, A-Lum
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (24)
  • [50] Metabolic dysfunction-associated fatty liver disease in people living with HIV
    Maurice Michel
    Christian Labenz
    Angelo Armandi
    Leonard Kaps
    Wolfgang Maximilian Kremer
    Peter R. Galle
    Daniel Grimm
    Martin Sprinzl
    Jörn M. Schattenberg
    Scientific Reports, 13